Tcr2 Therapeutics Inc

NASDAQ:TCRR   3:59:51 PM EDT
2.12
-0.04 (-1.85%)
Earnings Announcements

TCR Therapeutics Reports First Quarter 2022 Financial Results And Provides Corporate Update

Published: 05/12/2022 11:05 GMT
Tcr2 Therapeutics Inc (TCRR) - Tcr² Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Expect Cash on Hand to Support Operations Into 2024.
Qtrly Loss per Share $0.76.
Q1 Earnings per Share View $-0.74 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.78

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.